Development of a biotechnological process for the
inhalational administration of a bacteriophage was pursued,
using strategies of nanoencapsulation within lipid
nanovesicles. As a proof-of-concept for the
nanoencapsulation strategy, a bacteriophage with broad
lytic spectrum was entrapped within W/O/W multiple
nanoemulsions. Physicochemical characterization of the
optimized bacteriophage-encasing nanovesicles
encompassed determination of particle hydrodynamic size,
size distribution and particle charge via DLS, surface
morphology via CRYO-SEM, and thermal analysis via
DSC, whereas antimicrobial activity of the nanoemulsions
produced was assessed in vitro using several bacterial
strains. The optimized nanosystems showed no phase
separation and encompassed nanovesicles with an average
size of ca. 114 nm and an average Zeta Potential of ca. -13
mV, which were maintained stable over a storage
timeframe of ca. 3 months.(undefined